8-K
Shuttle Pharmaceuticals Holdings, Inc. Engages New Independent Registered Public Accounting Firm
8-K
Shuttle Pharmaceuticals Holdings, Inc. Dismisses Independent Accounting Firm Forvis Mazars, LLP
8-K/A
Amendment clarifies that 9,741,751 pre-funded warrants were actually issued as of September 9, 2026, not the previously reported maximum.
8-K
Shuttle Pharmaceuticals Holdings, Inc. Announces Unregistered Sales of Equity Securities Following Stockholder Approval
8-K
Shuttle Pharmaceuticals Holdings, Inc. Announces Results of Special Meeting of Stockholders
8-K
Shuttle Pharmaceuticals Holdings, Inc. Postpones Special Meeting of Stockholders
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel ther...